3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor

Sharma, Ritesh; Thakar, Hardik; Vasu, Kamala; Chaturvedi, Subhash

doi:10.2478/v10007-008-0020-5

Abstract

An approach for binding affinity evaluation is suggested and exemplified using a set of triazolo [1,5-a] quinoxaline for the (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol--4-yl)-propionic acid (AMPA) receptor. Biological activity toward the AMPA receptor (expressed as --log IC₅₀) was taken as a dependent variable for building Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) models. The resulting models show the ways of increasing the binding affinity to the AMPA receptor as a potential target for epilepsy. The statistically significant results show that the cross-validated r²_CV value (0.766) for the CoMFA model is greater than (0.758) for the CoMSIA model. The non-cross validated run giving the coefficient of determination r² values of 0.944 and 0.919 for CoMFA and CoMSIA, respectively, provided good correlation between the observed and computed affinities of the training set compounds. The resulting CoMFA and CoMSIA models indicate that steric, electrostatic, hydrophobic (lipophilic), hydrogen bond donor and acceptor substituents play a significant role in increasing the binding affinity and selectivity of the compounds toward the AMPA receptor.

References

H. Bräuner-Osborne, J. Egebjerg, E. Ø. Nielsen, U. Madsen and P. Krogsgaard-Larsen, Ligands for glutamate receptor: Design and therapeutic prospects, J. Med. Chem. 43 (2000) 2609-2645; DOI: 10.1021/jm000007r.10.1021/jm000007r
Search in Google Scholar
R. Dingledine, K. Borges, D. Bowie and S. F. Traynelis, The glutamate receptor ion channels, Pharmacol. Rev. 51 (1999) 7-61.
Search in Google Scholar
M. Hollmann and S. Heinemann, Cloned glutamate receptors, Annu. Rev. Neurosci. 17 (1994) 103-108.
Search in Google Scholar
G. J. Lees, Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders, Drugs 59 (2000) 33-78; DOI: 10.2165/00003495-200059010-00004.10.2165/00003495-200059010-00004
Search in Google Scholar
U. Madsen, T. B. Stensbøl and P. Krogsgaard-Larsen, Inhibitors of AMPA and kainate receptors, Curr. Med. Chem. 8 (2001) 1291-1301.10.2174/0929867013372210
Search in Google Scholar
S. S. Nikam and B. E. Kornberg, AMPA receptor antagonists, Curr. Med. Chem. 8 (2001) 155-170.10.2174/0929867013373877
Search in Google Scholar
T. B. Stensbøl, U. Madsen and P. Krogsgaard-Larsen, The AMPA receptor binding site: Focus on agonists and competitive antagonists, Curr. Pharm. Des. 8 (2002) 857-872; DOI: 10.2174/1381612024607090.10.2174/1381612024607090
Search in Google Scholar
Y. P. Auberson, Competitive AMPA antagonism: A novel mechanism for antiepileptic drugs, Drugs Fut. 26 (2001) 463-471; DOI: 10.1358/dof.2001.026. 05.659545.
Search in Google Scholar
S. D. Donevan and M. Rogawski, GYKI 52466, a 2,3-benzodiazepine, is a highly selective, non-competitive antagonist of AMPA/kainate receptor responses, Neuron 10 (1993) 51-59; DOI: 10.1016/0896-6273(93)90241-I.10.1016/0896-6273(93)90241-I
Search in Google Scholar
A. Tortorella, T. Halonen, N. Sahibzada and K. Gale, A crucial role of the α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures, J. Pharmacol. Exp. Ther. 280 (1997) 1401-1405.
Search in Google Scholar
W. Löscher, Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy, Prog. Neurobiol. 54 (1998) 721-741; DOI: 10.1016/S0301-0082(97)00092-0.10.1016/S0301-0082(97)00092-0
Search in Google Scholar
W. Loscher, H. Lehmann, B. Behl, D. Seemann, H. J. Teschendorf, H. P. Hofmann, W. Lubisch, T. Hoger, H. G. Lemaire and G. Gross, A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy, Eur. J. Neurosci. 11 (1999) 250-262; DOI: 10.1046/j.1460-9568.1999.00432.x.10.1046/j.1460-9568.1999.00432.x9987029
Search in Google Scholar
G. R. Desraju, B. Gopalakrishnan, R. K. Jetti, A. Nagarjun, D. Raveendra, J. A. Sarma, M. E. Sobhia and R. Thiagavathi, Computer-aided design of selective cox-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives, J. Med. Chem. 45 (2002); DOI: 10.1021/jm020198t.10.1021/jm020198t12383010
Search in Google Scholar
M. T. Bohm. J. Sturzebecher and G. Klebe, Three dimensional quantitative structure activity relationship analysis using comparative molecular field analysis and comparative molecular similarity search analysis to elucidate selectivity differences of inhibitor binding to trypsin, thrombin and factor Xa, J. Med. Chem. 42 (1999) 458-477; DOI: 10.1021/jm981062r.10.1021/jm981062r9986717
Search in Google Scholar
D. Catarzi, V. Colotta, F. Varano, L. Cecchi, G. Filacchioni, A. Galli, C. Costagli and V. Carla, 7-Chloro-4,5-dihydro-8-(1,2,4-triazole-4-yl)-4-oxo-1,2,4-triazolo[1,5-a] quinoxaline-2-carboxylates as novel highly selective AMPA receptor antagonists, J. Med. Chem. 43 (2000) 3824-3826; DOI: 10.1021/jm0009686.10.1021/jm0009686
Search in Google Scholar
D. Catarzi, V. Colotta, F. Varano, L. Cecchi, G. Filacchioni, V. R. Calabri, A. Galli, C. Costagli and V. Carla, Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a] quinox -aline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists, J. Med. Chem. 47 (2004) 262-272; DOI: 10.1021/jm030906q.10.1021/jm030906q
Search in Google Scholar
D. Catarzi, V. Colotta, F. Varano, L. Cecchi, G. Filacchioni, A. Galli, C. Costagli and V. Carla, Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a] quinoxaline-2-carboxylates analogues of TQX-173, J. Med. Chem. 44 (2001) 3157-3165; DOI: 10.1021/jm010862q.10.1021/jm010862q
Search in Google Scholar
F. Varano, D. Catarzi, V. Colotta, G. Filacchioni, A. Galli, C. Costagli and V. Carla, Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists, J. Med. Chem. 45 (2002) 1035-1044; DOI: 10.1021/jm010995b.10.1021/jm010995b
Search in Google Scholar
Y. C. Cheng and W. H. Prusoff, Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC₅₀) of an enzymatic reaction, Biochem. Pharmacol. 22 (1973) 3099-3108; DOI: 10.1016/0006-2952(73)90196-2.10.1016/0006-2952(73)90196-2
Search in Google Scholar

3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor

Abstract

Paradigm

My account